XenoSite

Azilsartan medoxomil anion

CHEBI
Phase 1ReactivityEpoxidationQuinonationN-DealkylationUGT Conjugation
Azilsartan medoxomil anion Epoxidation prediction
CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(C2=CC3OC3C=C2c2nc(=O)o[n-]2)cc1 stable oxygenation prediction
CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(C2=CC3OC3C=C2c2nc(=O)o[n-]2)cc1 unstable oxygenation prediction
CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(C2=CC3OC3C=C2c2nc(=O)o[n-]2)cc1 dehydrogenation prediction
CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(C2=CC3OC3C=C2c2nc(=O)o[n-]2)cc1 reduction prediction
CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(C2=CC3OC3C=C2c2nc(=O)o[n-]2)cc1 hydrolysis prediction

(11c)acetic acid

CHEBI
dealkylation · 0.33
(11c)acetic acid
Probability scale from 0.0 to 1.0